Results 71 to 80 of about 8,784 (177)

Multiple Myeloma as the Underlying Cause of Thrombotic Microangiopathy Leading to Acute Kidney Injury: Revisiting a Very Rare Entity

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2017
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consumptive thrombocytopenia, and microangiopathic hemolytic anemia, leading to end-organ ischemia and infarction, affecting particularly the kidney and brain.
Savneek Chugh MD   +4 more
doaj   +1 more source

Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?

open access: yes, 2012
BACKGROUND AND OBJECTIVES: Atypical hemolytic uremic syndrome is a disease associated with mutations in the genes encoding the complement regulators factors H and I.
Pietro Roversi   +44 more
core   +1 more source

Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab

open access: yes, 2018
Bevacizumab (Avastin) is a recombinant humanized monoclonal antibody used for the management of various solid malignancies including colorectal, lung, brain, renal, and ovarian cancers as well as age-related macular degeneration of the eye.
Daulath Singh   +4 more
core   +1 more source

Hemolytic Uremic Syndrome in Pregnancy and Postpartum

open access: yes, 2017
BACKGROUND: Pregnancy is associated with various forms of thrombotic microangiopathy, including hemolytic uremic syndrome. A previous small French study suggested that pregnancy-associated hemolytic uremic syndrome was to be included in the spectrum of ...
Remuzzi, G.   +25 more
core   +1 more source

Hemolytic uremic syndrome and IgA nephropathy in a child: Coincidence or not?

open access: yesThe Turkish Journal of Pediatrics, 2018
A previously healthy 18-month old boy, presenting with diarrhea, anemia, thrombocytopenia and acute renal failure was admitted to our hospital. Hemolytic uremic syndrome (HUS) was diagnosed with his clinical and laboratory findings.
Serra Sürmeli-Döven   +7 more
doaj   +1 more source

Current treatment of atypical hemolytic uremic syndrome

open access: yesIntractable & Rare Diseases Research, 2014
Tremendous advances have been made in understanding the pathogenesis of atypical Hemolytic Uremic Syndrome (aHUS), an extremely rare disease. Insights into the molecular biology of aHUS resulted in rapid advances in treatment with eculizumab (Soliris(®), Alexion Pharmaceuticals Inc.).
S. Kaplan, Bernard   +3 more
openaire   +3 more sources

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome

open access: yes, 2014
Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core  

Rare Presentation of Atypical Hemolytic Uremic Syndrome in an Adult

open access: yes, 2021
Thrombotic microangiopathies (TMA) are disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microthrombi leading to organ dysfunction.
Cook, Christopher   +3 more
core   +1 more source

Clinical case of thrombotic microangiopathy in obstetric practice

open access: yesСеченовский вестник, 2017
Trombotic microangiopathy is heterogeneous group of the diseases united by a community of a histological and clinical implications at difference of pathogenetic mechanisms, presents clinical-morphological syndrome characterizing a lesion of vessels of a ...
M. N. Mochalova   +5 more
doaj  

A Case of Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome

open access: yesAnnals of Internal Medicine: Clinical Cases
Atypical hemolytic uremic syndrome (aHUS) is a rare non-Shiga toxin thrombotic microangiopathy caused by uncontrolled activation of the alternative complement pathway.
Kwasi Opare-Addo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy